---
title: "為什麼 Elanco Animal Health 的股票在週四大幅上漲？"
description: "Elanco 公佈第二季度銷售額為 12.4 億美元，超出預期，同比增長 5%；調整後的每股收益為 0.26 美元，同比下降 13%。寵物健康收入增長 11%，達到 6.43 億美元；Seresto 和 Advantage 系列分別貢獻了 1.13 億美元和 1.47 億美元"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/252079648.md"
published_at: "2025-08-07T16:39:45.000Z"
---

# 為什麼 Elanco Animal Health 的股票在週四大幅上漲？

> Elanco 公佈第二季度銷售額為 12.4 億美元，超出預期，同比增長 5%；調整後的每股收益為 0.26 美元，同比下降 13%。寵物健康收入增長 11%，達到 6.43 億美元；Seresto 和 Advantage 系列分別貢獻了 1.13 億美元和 1.47 億美元

Elanco posted Q2 sales of $1.24 billion, beating estimates and growing 5% YoY; adjusted EPS was $0.26, down 13% YoY. Pet Health revenue rose 11% to $643 million; Seresto and Advantage lines contributed $113 million and $147 million, respectively.

### Related Stocks

- [ELAN.US - Elanco Animal Health](https://longbridge.com/zh-HK/quote/ELAN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| How New Pet Screwworm Treatment And Pipeline Moves At Elanco (ELAN) Have Changed Its Investment Story | Elanco Animal Health is reshaping its pet health portfolio with FDA approval for Credelio Quattro-CA1 and advancing Befr | [Link](https://longbridge.com/zh-HK/news/270529155.md) |
| Elanco Animal Health to Participate in J.P. Morgan Healthcare Conference | Elanco Animal Health Inc. will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026. Pre | [Link](https://longbridge.com/zh-HK/news/271653954.md) |
| Elanco Secures USDA Approval For Befrena, Expands Dermatology Portfolio | Elanco Animal Health Inc. has received USDA approval for Befrena, a new anti-IL31 monoclonal antibody injection for trea | [Link](https://longbridge.com/zh-HK/news/271263545.md) |
| Douglas Lane & Associates LLC Cuts Stake in Elanco Animal Health Incorporated $ELAN | Douglas Lane & Associates LLC reduced its stake in Elanco Animal Health by 1.9% in Q3, owning 3,444,268 shares worth $69 | [Link](https://longbridge.com/zh-HK/news/270400133.md) |
| VP Modi Buys 4,500 ($96K) Of Elanco Animal Health Inc [ELAN] | Modi Rajeev A Vice President of Elanco Animal Health Inc [ELAN] filed a Form 4 on December 15, 2025 with the Securities  | [Link](https://longbridge.com/zh-HK/news/269774228.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。